Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals

BJU International

Volumn 103, Issue 6, 2009, Pages 826-835

  Cook, Alison F ^b   Grover, Phulwinder K ^b   Ryall, Rosemary L ^a,b  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Biomineralization; Calcium oxalate; Human serum albumin; Intracrystalline protein; Prothrombin fragment 1; Urolithiasis

Indexed keywords

4 CARBOXYGLUTAMIC ACID; HUMAN SERUM ALBUMIN; PROTHROMBIN; PROTHROMBIN FRAGMENT 1; UNCLASSIFIED DRUG; WHEWELLITE;

ADSORPTION; ARTICLE; BINDING AFFINITY; BIOMINERALIZATION; FLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROTEIN INTERACTION; URINALYSIS; UROLITHIASIS; X RAY CRYSTALLOGRAPHY;

CALCIUM OXALATE; CRYSTALLIZATION; HUMANS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTHROMBIN; SERUM ALBUMIN; URINARY CALCULI; UROLITHIASIS;

EID: 61349163530     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08195.x     Document Type: Article

References (50)

1. Mann S. Molecular tectonics in biomineralization and biomimetic materials chemistry. Nature 1993 365 : 499 505
2. Heuer AH, Fink DJ, Laraia VJ et al. Innovative materials processing strategies: a biomimetic approach. Science 1992 255 : 1098 105
3. Berman A, Addadi L, Weiner S. Interactions of sea-urchin skeleton macromolecules with growing calcite crystals - a study of intracrystalline proteins. Nature 1988 331 : 546 8
4. Aizenberg J, Ilan M, Weiner S, Addadi L. Intracrystalline macromolecules are involved in the morphogenesis of calcitic sponge spicules. Connect Tissue Res 1996 34 : 255 61
5. Veis A. Mineralization in organic matrix frameworks. Rev Miner Geochem 2003 54 : 249 89
6. Ryall RL, Cook AF, Thurgood LA, Grover PK. Macromolecules relevant to stone formation. In Evans, AP, Lingeman, JE, Williams, JC Jr eds, Renal Stone Disease: 1st Annual International Urolithiasis Research Symposium: Indianapolis, Indiana, 2-3 November 2006. Melville : American Institute of Physics, 2007 : 129 40
7. Canales BK, Anderson L, Higgins L et al. Second prize: comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix. J Endourol 2008 22 : 1161 7
8. Morse RM, Resnick MI. A new approach to the study of urinary macromolecules as participant in calcium oxalate crystallization. J Urol 1988 139 : 869 73
9. Doyle IR, Ryall RL, Marshall VR. Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. Clin Chem 1991 37 : 1589 94
10. Stapleton AM, Ryall RL. Crystal matrix protein - getting blood out of a stone. Miner Electrolyte Metab 1994 20 : 399 409
11. Ryall RL, Grover PK, Thurgood LA, Chauvet MC, Fleming DE, van Bronswijk W. The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals. Urol Res 2007 35 : 1 14
12. Ryall RL. Macromolecules and kidney stone formation: waste of space or space for waste? Segura J, Khoury S, Pak C, Preminger GM, Tolley D, Stone Disease. Paris : Health Publications Editions, 2003 : 69 79
13. Stapleton AM, Timme TL, Ryall RL. Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease. Br J Urol 1998 81 : 666 72
14. Stapleton AM, Dawson CJ, Grover PK et al. Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix. Kidney Int 1996 49 : 880 8
15. Ryall RL, Grover PK, Stapleton AMF et al. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci (Lond) 1995 89 : 533 41
16. Grover PK, Ryall RL. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. Eur J Biochem 1999 263 : 50 6
17. Grover PK, Ryall RL. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity. Clin Sci (Lond) 2002 102 : 425 34
18. Guo S, Ward MD, Wesson JA. Direct visualization of calcium oxalate monohydrate crystallization and dissolution with atomic force microscopy and the role of polymeric additives. Langmuir 2002 18 : 4284 91
19. Jung T, Sheng X, Choi CK, Kim WS, Wesson JA, Ward MD. Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy. Langmuir 2004 20 : 8587 96
20. Sheng X, Jung T, Wesson JA, Ward MD. Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents. Proc Natl Acad Sci USA 2005 102 : 267 72
21. Qiu SR, Wierzbicki A, Orme CA et al. Molecular modulation of calcium oxalate crystallization by osteopontin and citrate. Proc Natl Acad Sci USA 2004 101 : 1811 5
22. Qiu SR, Wierzbicki A, Salter A et al. Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps. J Am Chem Soc 2005 127 : 9036 44
23. De Yoreo JJ, Qiu SR, Hoyer JR. Molecular modulation of calcium oxalate crystallization. Am J Physiol Renal Physiol 2006 291 : F1123 32
24. Taller A, Grohe B, Rogers KA, Goldberg HA, Hunter GK. Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals. Biophys J 2007 93 : 1768 77
25. Grohe B, O'Young JO, Ionescu A et al. Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide. J Am Chem Soc 2007 129 : 14946 51
26. Tazzoli V, Domeneghetti C. The crystal structures of whewellite and weddellite: re-examination and comparison. Am Mineral 1980 65 : 327 34
27. Millan A. Crystal growth shape of whewellite polymorphs: influence of structure distortions on crystal shape. Crystal Growth Design 2001 1 : 245 54
28. Deganello S, Piro OE. The crystal structure of calcium oxalate monohydrate (whewellite). Neues Jahrb Mineral 1981 2 : 81 8
29. Kahr B, Gurney RW. Dyeing crystals. Chem Rev 2001 101 : 893 951
30. Grover PK, Moritz RL, Simpson RJ, Ryall RL. Inhibition of growth and aggregation of calcium oxalate crystals in vitro- a comparison of four human proteins. Eur J Biochem 1998 253 : 637 44
31. Hess B, Ryall RL, Kavanagh JP et al. Methods for measuring crystallization in urolithiasis research: why, how and when? Eur Urol 2001 40 : 220 30
32. Bezeaud A, Guillin MC. Quantitation of prothrombin activation products in human urine. Br J Haematol 1984 58 : 597 606
33. Roberts WL, McMillin GA, Burtis CA et al. Reference information for the clinical laboratory. In Burtis CA, Ashwood ER, Bruns DE, Teitz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th edn, Section VII, Chapt. 56. St Louis : Elsevier Saunders, 2006 : 2254
34. Li L, Darden T, Foley C, Hiskey R, Pedersen L. Homology modeling and molecular dynamics simulation of human prothrombin fragment 1. Protein Sci 1995 4 : 2341 8
35. 2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 1992 31 : 2554 66
36. Megyes T, Bakó I, Bálint S, Grósz T, Radnai T. Ion pairing in aqueous calcium chloride solution: molecular dynamics simulation and diffraction studies. J Mol Liquids 2006 129 : 63 74
37. Huang M, Rigby AC, Morelli X et al. Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol 2003 10 : 751 6
38. Iwata H, Kamei O, Abe Y et al. The organic matrix of urinary uric acid crystals. J Urol 1988 139 : 607 10
39. Khan SR. Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate. J Urol 1997 157 : 376 83
40. Boevé ER, Ketelaars GAM, Vermeij M, Cao LC, Schröder FH, De Bruijn WC. An ultrastructural study of experimentally induced microliths in rat proximal and distal tubules. J Urol 1993 149 : 893 9
41. Ryall RL, Chauvet MC, Grover PK. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. BJU Int 2005 96 : 654 63
42. Ryall RL, Fleming DE, Grover PK, Chauvet MC, Dean CJ, Marshall VR. The hole truth: intracrystalline proteins and calcium oxalate kidney stones. Mol Urol 2000 4 : 391 402
43. Ryall RL, Fleming DE, Doyle IR, Evan NA, Dean CJ, Marshall VR. Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formation. J Struct Biol 2001 134 : 5 14
44. Fleming DE, van Reissen A, Chauvet MC et al. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate. J Bone Miner Res 2003 18 : 1282 91
45. Touryan LA, Clark RH, Gurney RW, Stayton PS. Incorporation of fluorescent molecules and proteins into calcium oxalate monohydrate single crystals. J Cryst Growth 2001 233 : 380 8
46. Fleming DE, van Bronswijk W, Ryall RL. A comparative study of the adsorption of amino acids on calcium minerals found in renal calculi. Clin Sci (Lond) 2001 101 : 159 68
47. De Yoreo JJ, Dove PM. Materials science. Shaping crystals with biomolecules. Science 2004 306 : 1301-2
48. 2+ ion-mediated binding of prothrombin fragment 1 to phospholipid vesicles and a molecular model for its association with phospholipids. J Biol Chem 1979 254 : 5027 40
49. Gul A, Rez P. Models for binding to calcium oxalate surfaces. Urol Res 2007 35 : 63 71
50. Dawson CJ, Grover PK, Ryall RL. Inter-α-trypsin inhibitor in urine and calcium oxalate urinary crystals. Br J Urol 1997 81 : 20 6